These 22 Biotechs Collectively Raised $3.3 Billion in Q1 2024. What Do They Have to Offer?
The biotech industry is experiencing a big wave of investment, similar to the high levels seen between 2020 and 2021.
In just the last three months, there's been a rush of big money deals, with companies like Engrail Tx, Clasp Tx, Capstan Tx, and Mirador Tx announcing large funding amounts of $157 million, $150 million, $175 million, and $400 million, respectively.
Since the beginning of the year, 22 biotech startups have raised over $100 million each (see table below).
Investors are showing interest in companies that are close to or in the middle of clinical trials, which means they're testing their treatments on people. For instance, out of the 22 biotech startups with significant rounds in 2024, only 6 are in the preclinical stage.
Another quite expected insight seen from the table is that the majority of them, 10 companies, are focused on oncology as the key area.
Topics: Startups & Deals